Qiming Venture Partners USA
Qiming Venture Partners is a venture capital firm that offers early-stage healthcare possibilities in highly disruptive platforms.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Qiming Venture Partners USA Information
Geographic Data
Address: 2101 4th Avenue
City: Seattle
State: WA
Zip: 98121
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$260M
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
4,743,079Website Global Rank
1,829Website Monthly Traffic
Twitter Followers
Description
Qiming Venture Partners invests in young, fast-growing companies across China in the media and internet, IT, consumer and retail, healthcare, and clean technology sectors. we are early to growth stage venture capital firm with offices in Shanghai, Beijing and Hong Kong. Since their debut in 2006, we have established their selves as a leading investment firm in China and currently manage four funds with over $1 billion in assets.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2021 | Kira Pharmaceuticals | Series B | 53.5M |
| 10/2019 | Icosavax | Series A | 0 |
| 1/2021 | Auron Therapeutics | Seed Round | 0 |
| 11/2020 | Umoja Biopharma | Series A | 53M |
| 1/2020 | Jasper Therapeutics | Series A | 14.1M |
| 9/2020 | Korro Bio | Series A | 0 |
| 5/2020 | LetsGetChecked | Series C | 71M |
| 7/2020 | Elevation Oncology | Series A | 32.5M |
| 9/2021 | Jasper Therapeutics | Post-IPO Equity | 0 |
| 12/2019 | Jasper Therapeutics | Series A | 35M |
| 7/2015 | Zhaosuliao | Series B | 36M |
| 11/2020 | Elevation Oncology | Series B | 65M |
| 12/2022 | Entact Bio | Series A | 81M |
| 9/2022 | Soda Health | Series A | 25M |
| 9/2021 | Ventyx Biosciences | Series B | 0 |
| 3/2020 | Element Science | Series C | 145.6M |
| 6/2022 | Boulder Care | Series B | 0 |
| 6/2021 | LetsGetChecked | Series D | 150M |
| 4/2021 | Icosavax | Series B | 0 |
| 8/2021 | Soda Health | Seed | 6M |
| 7/2022 | Auron Therapeutics | Series A | 0 |
| 1/2022 | Korro Bio | Series B | 0 |
| 3/2021 | Ventyx Biosciences | Series A | 0 |
| 10/2020 | Talaris Therapeutics | Series B | 0 |
| 9/2021 | HilleVax | Equity | 135M |
| 7/2022 | Auron Therapeutics | Series A | 0 |
| 6/2022 | Boulder Care | Series B | 0 |
| 1/2022 | Korro Bio | Series B | 0 |
| 9/2021 | Jasper Therapeutics | Post-IPO Equity | 0 |
| 9/2021 | Ventyx Biosciences | Series B | 0 |
| 8/2021 | Soda Health | Seed Round | 0 |
| 6/2021 | LetsGetChecked | Series D | 0 |
| 4/2021 | Icosavax | Series B | 0 |
| 3/2021 | Ventyx Biosciences | Series A | 0 |
| 1/2021 | Auron Therapeutics | Seed Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
